Huang, Yu-Hwa
Zhu, Chen
Kondo, Yasuyuki
Anderson, Ana C.
Gandhi, Amit
Russell, Andrew
Dougan, Stephanie K.
Petersen, Britt-Sabina
Melum, Espen
Pertel, Thomas
Clayton, Kiera L.
Raab, Monika
Chen, Qiang
Beauchemin, Nicole
Yazaki, Paul J.
Pyzik, Michal
Ostrowski, Mario A.
Glickman, Jonathan N.
Rudd, Christopher E.
Ploegh, Hidde L.
Franke, Andre
Petsko, Gregory A.
Kuchroo, Vijay K.
Blumberg, Richard S.
Article History
Received: 9 December 2013
Accepted: 8 September 2014
First Online: 26 October 2014
Change Date: 9 February 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-024-07164-y
Competing interests
: V.K.K. and A.C.A. are consultants to Novartis, which is developing immune modulators for the treatment of cancer; R.S.B. and all other authors declare no competing financial interests.